
The Cancer Research UK Pension Scheme has completed a £280m buy-in deal with Standard Life.
The bulk purchase annuity (BPA) transaction – completed in March using a "bespoke offering" – secures the benefits of 2,800 scheme members. Mercer was lead transaction adviser to the trustee, wh...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders